DarioHealth - DRIO EV/Sales Multiple

Public company logo of DarioHealth Corp (DRIO)

DarioHealth Corp. (DRIO) is integrating generative AI into its digital services to combat chronic conditions. However, local data laws and chip supply disruptions from Asia are hindering the software's expansion across Europe and the US. Diversification through support for hypertensive and diabetic patients is attracting insurance funds. The EV/Sales trajectory visualizes the real value of sales, where the 810.80 level indicates the status of the parameter.

DarioHealth Corp (DRIO) - Company Value to Revenue from 11/23/2025 to 11/20/2026

Financial and market metric breakdowns for DarioHealth Corporation (DRIO)

Fundamental company valuation:DarioHealth Corp.
Product sample of DarioHealth Corp

The hybrid model of DarioHealth Corp. (DRIO), which combines proprietary IT solutions with outsourced electronics manufacturing, requires an enterprise value assessment that excludes debt load. This multiple compares the total enterprise value to its revenue, determining the actual margin of safety and the market recognition of assets. By analyzing the EV/Sales ratio of DarioHealth Corp. (DRIO), an investor can identify an overvaluation or undervaluation of fundamental value, taking into account revenue volatility risks.